Reduced dose and contrast volume compared to the standard procedure
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: R688- Other general symptoms and signs
- Registration Number
- CTRI/2021/09/036954
- Lead Sponsor
- Cauvery Sirdeshpande
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients referred for CT neck and thorax during the study
2. 18 years and above
Exclusion Criteria
1. Patients referred for CT neck/CT thorax separately
2. Uncooperative patients
3. Patients with any previous history of allergy to contrast media
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the primary clinical endpoints in the CTRI/2021/09/036954 trial comparing low-dose CT protocols for neck and thorax imaging?
How does low-dose CT with reduced contrast volume compare to standard protocols in minimizing radiation exposure while maintaining diagnostic efficacy in neck and thorax imaging?
Are there specific biomarkers that identify patients suitable for low-dose CT neck and thorax imaging without compromising diagnostic outcomes?
What are the safety profiles and adverse event management strategies for low-dose CT protocols with reduced contrast volume in neck and thorax imaging?
How do alternative contrast agents or imaging modalities compare to low-dose CT in neck and thorax imaging for R688-related symptom evaluation?